Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Altering macrophage polarization in the tumor environment: the role of response gene to complement 32.

Literature DB >> 25418471

Altering macrophage polarization in the tumor environment: the role of response gene to complement 32.

Matteo Santoni¹, Stefano Cascinu¹, Charles D Mills².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 25418471 PMCID： PMC4716620 DOI： 10.1038/cmi.2014.115

Source DB: PubMed Journal: Cell Mol Immunol ISSN： 1672-7681 Impact factor: 11.530

× No keyword cloud information.

10 in total

Review 1. M1 and M2 Macrophages: Oracles of Health and Disease.

Authors: Charles D Mills
Journal: Crit Rev Immunol Date: 2012 Impact factor: 2.214

2. M1 and M2 macrophages: the chicken and the egg of immunity.

Authors: Charles D Mills; Klaus Ley
Journal: J Innate Immun Date: 2014-08-13 Impact factor: 7.349

3. Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.

Authors: Peng Zhao; Daiqing Gao; Qingjie Wang; Bingfeng Song; Qianqian Shao; Jintang Sun; Chunyan Ji; Xingang Li; Peng Li; Xun Qu
Journal: Cell Mol Immunol Date: 2014-11-24 Impact factor: 11.530

4. The phenotype of murine wound macrophages.

Authors: Jean M Daley; Samielle K Brancato; Alan A Thomay; Jonathan S Reichner; Jorge E Albina
Journal: J Leukoc Biol Date: 2010-01 Impact factor: 4.962

5. Temporal expression of different pathways of 1-arginine metabolism in healing wounds.

Authors: J E Albina; C D Mills; W L Henry; M D Caldwell
Journal: J Immunol Date: 1990-05-15 Impact factor: 5.422

6. Macrophage arginine metabolism and the inhibition or stimulation of cancer.

Authors: C D Mills; J Shearer; R Evans; M D Caldwell
Journal: J Immunol Date: 1992-10-15 Impact factor: 5.422

Review 7. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.

Authors: Matteo Santoni; Francesco Massari; Consuelo Amantini; Massimo Nabissi; Francesca Maines; Luciano Burattini; Rossana Berardi; Giorgio Santoni; Rodolfo Montironi; Giampaolo Tortora; Stefano Cascinu
Journal: Cancer Immunol Immunother Date: 2013-10-17 Impact factor: 6.968

8. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.

Authors: J B Hibbs; Z Vavrin; R R Taintor
Journal: J Immunol Date: 1987-01-15 Impact factor: 5.422

Review 9. Tumor-associated macrophages: from mechanisms to therapy.

Authors: Roy Noy; Jeffrey W Pollard
Journal: Immunity Date: 2014-07-17 Impact factor: 31.745

10. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors: Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal: Nat Med Date: 2013-09-22 Impact factor: 53.440

10 in total

6 in total

Altering macrophage polarization in the tumor environment: the role of response gene to complement 32.

Review 1. M1 and M2 Macrophages: Oracles of Health and Disease.

2. M1 and M2 macrophages: the chicken and the egg of immunity.

3. Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.

4. The phenotype of murine wound macrophages.

5. Temporal expression of different pathways of 1-arginine metabolism in healing wounds.

6. Macrophage arginine metabolism and the inhibition or stimulation of cancer.

Review 7. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.

8. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.

Review 9. Tumor-associated macrophages: from mechanisms to therapy.

10. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

1. Deletion of Lactate Dehydrogenase-A in Myeloid Cells Triggers Antitumor Immunity.

2. New insights into the roles of RGC-32.

Review 3. Short Review on Advances in Hydrogel-Based Drug Delivery Strategies for Cancer Immunotherapy.

Review 4. New opportunities for nanoparticles in cancer immunotherapy.

Review 5. Emerging nanomedicines for effective breast cancer immunotherapy.

Review 6. Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy.